Cargando…

Lung Cancer with Brain Metastases Treated with Radiotherapy Followed by Bevacizumab Maintenance: A Case Report

Brain metastases in a patient with non-small cell lung cancer carry a grave prognosis. Without effective interventions, the average survival rate is 6 months. Here, we present a case of a 59-year-old male with non-small cell lung cancer and multiple brain metastases treated with radiotherapy followe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Khan, Sajjad Ahmed, Gautam, Sakshyam, Sapkota, Sulav
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Journal of the Nepal Medical Association 2022
Materias:	Case Report
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9275467/ https://www.ncbi.nlm.nih.gov/pubmed/35690983 http://dx.doi.org/10.31729/jnma.7400

Ejemplares similares

Bevacizumab reduces peritumoral brain edema in lung cancer brain metastases after radiotherapy
por: Hua, Yi‐Chun, et al.
Publicado: (2023)

Clinico-epidemiological profile of cerebrovascular accident in eastern Nepal: A descriptive cross-sectional study
por: Rauniyar, Vivek K., et al.
Publicado: (2023)

Perfusion imaging of colorectal liver metastases treated with bevacizumab and stereotactic body radiotherapy
por: Detsky, Jay S., et al.
Publicado: (2018)

Promising Response of Paclitaxel in Metastatic Transitional Cell Carcinoma of Distal Ureter Complicated with Hydroureteronephrosis: A Case Report
por: Khan, Sajjad Ahmed, et al.
Publicado: (2023)

Addition of Anti-Angiogenetic Therapy with Bevacizumab to Chemo- and Radiotherapy for Leptomeningeal Metastases in Primary Brain Tumors
por: Burger, Michael C., et al.
Publicado: (2016)

Management of initial and recurrent radiation-induced contrast enhancements following radiotherapy for brain metastases: Clinical and radiological impact of bevacizumab and corticosteroids
por: Meixner, Eva, et al.
Publicado: (2023)

Clinical outcomes of gastrointestinal brain metastases treated with radiotherapy
por: Sanghvi, Samrat M., et al.
Publicado: (2017)

Bevacizumab for radiation necrosis following radiotherapy of brain metastatic disease: a systematic review & meta-analysis
por: Khan, Muhammad, et al.
Publicado: (2021)

Bevacizumab for the treatment of non-small cell lung cancer patients with synchronous brain metastases
por: Ascha, Mustafa S., et al.
Publicado: (2019)

Upfront FOLFOXIRI+bevacizumab followed by fluoropyrimidin and bevacizumab maintenance in patients with molecularly unselected metastatic colorectal cancer
por: Stein, Alexander, et al.
Publicado: (2015)

Advances in radiotherapy for brain metastases
por: Gondi, Vinai, et al.
Publicado: (2021)

Quality of Life in Patients Treated with Palliative Radiotherapy for Advanced Lung Cancer and Lung Metastases
por: Koo, Kaitlin, et al.
Publicado: (2011)

Bevacizumab and gefitinib enhanced whole-brain radiation therapy for brain metastases due to non-small-cell lung cancer
por: Yang, R.F., et al.
Publicado: (2017)

A Successfully Resected Case of Recurrent Lung and Liver Metastases of Rectal Cancer Treated with XELIRI + Bevacizumab Therapy
por: Aisu, Naoya, et al.
Publicado: (2013)

Whole brain radiotherapy with radiosensitizer for brain metastases
por: Viani, Gustavo Arruda, et al.
Publicado: (2009)

Pituitary hyperplasia due to Himalayan endemic hypothyroidism
por: Sapkota, Shabal, et al.
Publicado: (2020)

Transarterial chemoembolization alone or followed by bevacizumab for treatment of colorectal liver metastases
por: Fiorentini, Giammaria, et al.
Publicado: (2021)

Lung metastases treated with stereotactic body radiotherapy: the RSSearch® patient Registry’s experience
por: Ricco, Anthony, et al.
Publicado: (2017)

Phase II study of pemetrexed and carboplatin plus bevacizumab, followed by maintenance pemetrexed and bevacizumab in Japanese patients with non-squamous non-small cell lung cancer
por: YOKOI, TAKASHI, et al.
Publicado: (2014)

Role of Palliative Radiotherapy in Brain Metastases
por: Bilimagga, Ramesh S, et al.
Publicado: (2009)

The Cognitive Effects of Radiotherapy for Brain Metastases
por: Lehrer, Eric J., et al.
Publicado: (2022)

Bevacizumab suppresses the growth of established non-small-cell lung cancer brain metastases in a hematogenous brain metastasis model
por: Masuda, Chinami, et al.
Publicado: (2019)

Serum lactate dehydrogenase predicts survival in small-cell lung cancer patients with brain metastases that were treated with whole-brain radiotherapy
por: Anami, Shimpei, et al.
Publicado: (2019)

Bevacizumab treatment of meningeal melanoma metastases
por: Simonsen, Trude G., et al.
Publicado: (2020)

MBCL-09. ISOLATED M1 METASTASES IN PEDIATRIC MEDULLOBLASTOMA: IS POSTOPERATIVE RADIOTHERAPY FOLLOWED BY MAINTENANCE CHEMOTHERAPY SUPERIOR TO POSTOPERATIVE SANDWICH-CHEMOTHERAPY AND RADIOTHERAPY?
por: Obrecht, Denise, et al.
Publicado: (2020)

LMAP-11 CYSTIC BRAIN METASTASES OUTCOMES FOLLOWING GAMMA KNIFE RADIOTHERAPY
por: Amidon, Ryan, et al.
Publicado: (2023)

Bevacizumab and risk of intracranial hemorrhage in patients with brain metastases: a meta-analysis
por: Yang, Lin, et al.
Publicado: (2017)

Bevacizumab-based treatment as salvage therapy in patients with recurrent symptomatic brain metastases
por: Berghoff, Anna Sophie, et al.
Publicado: (2020)

Phase II trial of carboplatin and bevacizumab in patients with breast cancer brain metastases
por: Leone, Jose Pablo, et al.
Publicado: (2020)

Pemetrexed/Carboplatin/Bevacizumab followed by Maintenance Pemetrexed/Bevacizumab in Hispanic Patients with Non-Squamous Non-Small Cell Lung Cancer: Outcomes according to Thymidylate Synthase Expression
por: Cardona, Andrés Felipe, et al.
Publicado: (2016)

PRONOUNCE: Randomized, Open-Label, Phase III Study of First-Line Pemetrexed + Carboplatin Followed by Maintenance Pemetrexed versus Paclitaxel + Carboplatin + Bevacizumab Followed by Maintenance Bevacizumab in Patients ith Advanced Nonsquamous Non–Small-Cell Lung Cancer
por: Zinner, Ralph G., et al.
Publicado: (2015)

Single institutional outcomes of whole brain radiotherapy for metastatic melanoma brain metastases
por: Jiang, Cecilia, et al.
Publicado: (2021)

Selection of prescription isodose line for brain metastases treated with volumetric modulated arc radiotherapy
por: Xu, Yuan, et al.
Publicado: (2019)

Coexisting Choroidal and Brain Metastases in a Patient with Breast Cancer Treated with Stereotactic Radiotherapy
por: Oliverio, Giovanni William, et al.
Publicado: (2022)

Upfront whole brain radiotherapy for multiple brain metastases in patients with EGFR-mutant lung adenocarcinoma
por: Li, Changhui, et al.
Publicado: (2019)

A Case of Brain Metastases from Breast Cancer Treated with Whole-Brain Radiotherapy and Eribulin Mesylate
por: Nieder, Carsten, et al.
Publicado: (2012)

Survival and level of care among breast cancer patients with brain metastases treated with whole brain radiotherapy
por: Frisk, Gabriella, et al.
Publicado: (2017)

Clinical characteristics of brain metastases from lung cancer according to histological type: Pretreatment evaluation and survival following whole-brain radiotherapy
por: KOMATSU, TETSUYA, et al.
Publicado: (2013)

A meta-analysis for the efficacy and safety of icotinib combined with radiotherapy in treating brain metastases of non-small cell lung cancer
por: Zhang, Bo
Publicado: (2023)

Efficacy and safety of antitumor agents plus radiotherapy compared with radiotherapy alone for brain metastases from lung cancer
por: Lin, Heng, et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_robu8qpca6js1agmtna0sr29sb